Navigation Links
Metabolex Appoints Raymond Urbanski M.D., Ph.D. to Position of Chief Medical Officer
Date:10/20/2011

e is being combined with the xanthine oxidase inhibitors allopurinol and febuxostat (Uloric™, Takeda Pharmaceutical Company Limited). The study using arhalofenate (400 and 600 mg) in combination with allopurinol is a randomized double-blind placebo-controlled study in patients who are refractory to allopurinol (do not reach their serum uric acid goal of <6 mg/dL). The primary endpoint is the percentage of patients that reach goal.  

The Phase 2b combination study with febuxostat is an open-label study in which 400 and 600 mg doses of arhalofenate are added on to febuxostat (80 mg) to assess how low uric acid levels can be driven.  This study is also fully enrolled. Data from all three Phase 2b studies will be available in the second quarter of 2012.  

"I am very excited about joining Metabolex and leading the arhalofenate gout program," said Ray Urbanski. "The Phase 2 program that is in place reflects the potential that arhalofenate has of achieving a broad label for the treatment of hyperuricemia and gout including first-line use and, for patients not reaching treatment goals, in combination with allopurinol or febuxostat, as well as addressing some common gout co-morbidities. Arhalofenate is a potential best-in-class drug that is highly de-risked and has tremendous commercial potential."  

Arhalofenate has previously completed eight Phase 1 and four Phase 2 studies in patients with Type 2 diabetes which demonstrate that it has excellent safety and tolerability in more than 550 patients for up to 6 months of treatment. The drug has completed all preclinical safety studies including the carcinogenicity studies and is therefore highly de-risked with regard to both preclinical and clinical safety.  

The clinical data from the diabetes trials showed that arhalofenate exhibited robust, dose-dependent reductions in serum uric acid.  These reductions were fully retained in patients with mild to moderate re
'/>"/>

SOURCE Metabolex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Metabolex Initiates Phase 2 Trial of Arhalofenate
2. Metabolex Announces Election of Kurt von Emster to Board of Directors
3. Metabolex Announces Positive Results From Phase 1a Clinical Trial of MBX-2982
4. Two Metabolex Projects Recognized in Windhovers Top 10 Lists for Partnering Opportunities
5. Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations
6. Kessler Foundation Appoints New Director of Human Performance and Engineering Laboratory
7. China Botanic Appoints Zack Zibing Pan as an Independent Director and Chairman of its Audit Committee
8. Immune Design Corp. Appoints Guy F. Cipriani as Chief Business Officer
9. Amgen Appoints Robert A. Bradway to the Companys Board of Directors
10. PrimeraDx Appoints Jeff Liter as VP of Corporate Development
11. Oncobiologics Appoints Scott Canute, Former President of Eli Lilly and Genzyme, to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Aug. 19, 2014 CSSi, the leader in ... announced the formation of the company,s Medical and Clinical ... addition of Dr. William E. Gannon, Jr. ... The MCAB, with Dr. Gannon,s ... therapeutic areas and set strategic goals for the advancement ...
(Date:8/19/2014)... Scottsdale, AZ (PRWEB) August 19, 2014 ... the launch of its online sales skills training ... their sales skills. , MedTech clinical staff spend the ... at a hospital, standalone medical center, or physician practice ... administrative staff. But why stop there? Sales Horizons believes ...
(Date:8/18/2014)... FREDERICK, Md. , Aug. 18, 2014 ... the maker of advanced consumer medical devices ... Kotak was interviewed by CEOLIVE.TV as ... The entire interview is available at ... interview Dr. Kotak explains to investors the ...
(Date:8/18/2014)... According to a new ... Science Reagents Market(Products- PCR Reagent Kits, Cell and ... Reagents and Others; End Users- Commercial and Contract ... Forensic Laboratories)- Global Industry Analysis, Size, Share, Growth, ... life science reagents market was valued at USD ...
Breaking Biology Technology:CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5
... (ZnO) are among the most technologically relevant semiconducting ... elements such as blue lasers (hence the blue-ray ... many uses in optoelectronics and sensors. In ... these materials have shown a plethora of potential ...
... SRI International, an independent nonprofit research and development ... by the Department of Energy (DOE) to expand its ... project will give SRI,s bioinformatics tools even greater utility ... derived from biological sources.   SRI will ...
... Jan. 26, 2011 Novel solutions to 21st century ... fourth annual executive education conference for female leaders in ... 2011. The Women Innovate Conference will feature ... business ranging from small start-ups to global corporations.  Together, ...
Cached Biology Technology:Nanowires exhibit giant piezoelectricity 2Nanowires exhibit giant piezoelectricity 3Department of Energy Funds SRI to Enhance Bioinformatics Tools for Renewable Energy Research 2Department of Energy Funds SRI to Enhance Bioinformatics Tools for Renewable Energy Research 3KGI Hosts Fourth Annual Conference for Women in Life Science Industry 2KGI Hosts Fourth Annual Conference for Women in Life Science Industry 3
(Date:8/20/2014)... 2014  The second annual Biometrics UnPlugged Executive ... Tampa, Florida on September 15, 2014, ... Technology and Strategy at Samsung, and Philippe de ... of this year,s event is Mobility at the ... "Biometrics UnPlugged: Mobility at the Crossroads of Commerce ...
(Date:8/19/2014)... 2014 To improve students, chances of completing ... University of Houston (UH) implemented a comprehensive student ... risk for failure. , Through a grant ... the Department of Biology and Biochemistry embarked on ... "General Biology" for non-majors and "Introductory Biology" for ...
(Date:8/19/2014)... in German . ... sources. If a large amount of electricity is to be ... will have to be stored during productive periods so that ... are far from adequate for the purpose. Science and industry ... lies on battery systems that used to be too expensive ...
Breaking Biology News(10 mins):Biometrics UnPlugged: Mobility at the Crossroads of Commerce & Privacy to Feature Interactive Sessions with Samsung and Experian 2University of Houson program earns kudos for improving grades, retaining students 2University of Houson program earns kudos for improving grades, retaining students 3Asian inventions dominate energy storage systems 2Asian inventions dominate energy storage systems 3
... Society of America presents a new Special Paper, Paleoenvironments ... This volume is the culmination of more than a decade ... long-lived Bear Lake, which is located 100 km northeast of ... the largest river in the Great Basin of the western ...
... remember Buckminster Fuller,s distinctive "geodesic domes" soccer-ball-shaped structures ... Tel Aviv University chemists remember them too and ... of multiple sclerosis (MS). In partnership with a ... Hospital at Harvard Medical School, Dr. Michael Gozin from ...
... and the Albert Einstein College of Medicine have ... (TB) and expose the deadly drug-resistant strains of ... strains. The researchers engineered bacteriophagestiny viruses that attack ... protein. They report their findings in the March ...
Cached Biology News:'Buckyballs' to treat multiple sclerosis 2Pitt-led researchers create quick, simple fluorescent detector for TB 2
... Extraction Software reads and processes ... prepare microarray data for analysis. ... one 1-year license for ... accounts ,one CD-ROM containing Feature ...
... Last innovation from Magnetofection technology, ... delivery system available. Simple, rapid and ... compatible and non toxic. Specifically designed ... gene silencing at very low doses ...
... handling system from Molecular Devices provides precise ... instrument. The system handles a variety of ... 384- and 1536-welland is the first to ... been optimized to dispense from four different ...
... Radiolabeled Ligands\n\nReceptor-related research has long been enabled ... ligands selected to keep pace with new ... products and services for receptor research and ... If you do not find exactly what ...
Biology Products: